Shanghai Pharmaceutical Group Co., Ltd. is the only pharmaceutical listed company in China that has a leading position in pharmaceutical products and distribution markets. The company's R&D is based on innovation as its long-term adherence to, and is committed to providing safe and effective therapeutic drugs for major diseases and chronic diseases. In 2012, R&D investment accounted for 4.72% of the company's pharmaceutical business sales revenue. The company has established a research and development system for the branch of the Group General Academy with the Central Research Institute as its technical core, with 1 national-level enterprise technology center and 10 provincial and municipal enterprise technology centers, and has been selected for more than ten major national science and technology projects of "major new drug creation". The company adopts an open research model, established a strategic alliance for innovative drug research and development with the Shanghai Institute of Pharmaceuticals of the Chinese Academy of Sciences, established joint laboratories with China Pharmaceutical University, Shenyang Pharmaceutical University, etc., and cooperated with Japan's Mitsubishi Tanabe Pharmaceutical Co., Ltd. and Shanghai Fudan Zhangjiang Biomedicine to carry out innovative drug research and development; at the same time, it also began to enter the field of therapeutic antibodies through project introduction, cooperative development and other methods.

Shanghai pharmaceutical manufacturing covers the fields of chemical and biological medicine, modern Chinese medicine and health products, medical devices, etc. The products focus on five major therapeutic areas: cardiovascular and cerebrovascular, systemic anti-infection, digestive system and immunometabolism, neuropsychiatric, and anti-tumor. It produces more than 20 dosage forms such as tablets, capsules, powder injections (including lyophilized), small-volume injections, eye drops, aerosols, gels, etc., and has over 100 million products. The company's Xinyi, Leishi, Longhu, Qingchunbao, Hu Qingyutang, Cangsong, Guofeng, Shenxiang and other brands are well-known trademarks in China. The company's pharmaceutical production strictly implements China's new version of GMP requirements, and multiple raw materials or preparations have passed the quality certification of WHO, FDA, the EU and other developed countries.

Shanghai Pharmaceutical's distribution network radiates across the country with the three key areas of East China, North China and South China, with the most economically developed in China, and ranks second in the country in terms of business scale. The company's distribution business is mainly hospital pure sales, and it cooperates with more than 40 multinational pharmaceutical companies around the world. The company's new businesses such as vaccines, high-end consumables, DTP (direct delivery of high-value drugs) and SPD (pharmaceutical flow management technology) are leading in China. The company's distribution services are gradually moving towards modern hospital service solutions with supply chain extension services and clinical support services as the core, providing hospital customers with terminal solutions, special logistics and information services.

Shanghai Pharmaceutical Retail has many well-known brands such as Fahrenheit, Lei Yunshang, Yu Tiancheng, Life Insurance, Leimon, Keyuan Xinhai Pharmacy, etc., covering 12 provinces, municipalities and autonomous regions across the country, with a total of 1,792 stores. In 2012, the company's pharmaceutical retail sales scale ranked among the top five in the national pharmaceutical retail industry, and Shanghai Fahrenheit Pharmacy is the company with the largest number of pharmacies in East China. Shanghai Pharmaceutical's retail business includes chain pharmacies, co-organized pharmacies, DTP pharmacies and other business formats, and actively develops e-commerce to achieve online sales.

Shanghai Pharmaceutical advocates the core corporate values ​​of "innovation, integrity, cooperation, inclusiveness, and responsibility", and is committed to perseverance, improving the people's healthy quality of life, and striving to build a leading brand drug manufacturer and health service provider that is respected and has an industry reputation.